Phase-variable control of multiple phenotypes in Acinetobacter baumannii strain AB5075

Journal of Bacteriology

Volumn 197, Issue 15, 2015, Pages 2593-2599

  Tipton, Kyle A ^a   Dimitrova, Daniela ^a   Rather, Philip N ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; GENTAMICIN; N ACYLHOMOSERINE LACTONE; RIFAMPICIN; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER BAUMANNII STRAIN AB5075; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOFILM; CELL DENSITY; CELL MOTILITY; CELL STRUCTURE; CELL SURFACE; COLONY FORMING UNIT; CONTROLLED STUDY; GALLERIA MELLONELLA; GENE FREQUENCY; GENETIC VARIABILITY; NONHUMAN; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; QUORUM SENSING; SIGNAL TRANSDUCTION; CLASSIFICATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY; VIRULENCE;

ACINETOBACTER BAUMANNII; GALLERIA MELLONELLA;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; PHENOTYPE; VIRULENCE;

EID: 84937019769     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00188-15     Document Type: Article

References (38)

1. Nemec A, Krizova L, Maixnerova M, van der Reijden T, Deschaght P, Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L. 2011. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii . nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 162:393-404. http://dx.doi.org/10.1016/j.resmic.2011.02.006.
2. Bergogne-Bérézin E, Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9:148-165.
3. Gootz TD, Marra A. 2008. Acinetobacter baumannii: an emerging multidrug- resistant threat. Exp Rev Anti Infect Ther 6:309-325. http://dx.doi .org/10.1586/14787210.6.3.309.
4. Joly-Guillou ML. 2005. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 11:868-873. http://dx.doi.org/10.1111/j.1469-0691.2005.01227.x.
5. Peleg AY, Seifert H, Patterson DL. 2008. Acinetobacter baumannii:emergence of a successful pathogen. Clin Microbiol Rev 21:538-582. http://dx.doi.org/10.1128/CMR.00058-07.
6. Scott PT, Petersen K, Fishbain J. 2004. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep 53:1063-1066.
7. Aronson NE, Sanders JW, Moran KA. 2006. In harm's way: infections in deployed American military forces. Clin Infect Dis 43:1045-1051. http://dx.doi.org/10.1086/507539.
8. Sebeny PJ, Riddle MS, Petersen K. 2008. Acinetobacter baumannii skin and soft tissue infection associated with war trauma. Clin Infect Dis 47:444-449. http://dx.doi.org/10.1086/590568.
9. Murray CK, Wilkins K, Molter NC, Li F, Yu Y, Sprott MA, Eastridge B, Blackbourne LH, Hospenthal DR. 2011. Infections complicating the care of combat casualties during operations Iraqi Freedom and Enduring Freedom. J Trauma 71(1 Suppl):S62-S73. http://dx.doi.org /10.1097/TA.0b013e3182218c99.
10. Murray CK, Hospenthal DR. 2005. Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis 18:502-506. http://dx.doi.org/10.1097/01.qco.0000185985.64759.41.
11. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. 2006. Analysis of antibiotic resistance genes in multidrugresistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50:4114-4123. http://dx.doi.org/10.1128/AAC.00778-06.
12. Rice LB. 2006. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 43(Suppl 2):S100-S105. http://dx.doi.org/10.1086/504487.
13. Perez F, Hujer AM, Hujer K, Decker BK, Rather PN, Bonomo RA. 2007. The challenge of multidrug antibiotic resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 51:3471-3484. http://dx.doi.org/10.1128/AAC.01464-06.
14. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals:multidrug resistant Acinetobacter baumannii. Nat Rev Microbiol 5:939-951. http://dx.doi.org/10.1038/nrmicro1789.
15. Queenan AM, Pillar CM, Deane J, Sahm DF, Lynch AS, Flamm RK, Peterson J, Davies TA. 2012. Multidrug resistance among Acinetobacter sp. in the US and activity profile of key agents: results from CAPITAL surveillance 2010. Diagn Microbiol Infect Dis 73:267-270. http://dx.doi .org/10.1016/j.diagmicrobio.2012.04.002.
16. Henderson IR, Owen P, Nataro JP. 1999. Molecular switches-the ON and OFF of bacterial phase variation. Mol Microbiol 33:919-932. http://dx.doi.org/10.1046/j.1365-2958.1999.01555.x.
17. Deitsch KW, Lukehart SA, Stringer JR. 2009. Common strategies for antigenic variation by bacterial fungal and protozoan pathogens. Nat Rev Microbiol 7:493-503. http://dx.doi.org/10.1038/nrmicro2145.
18. Swanson J. 1978. Studies on gonococcus infection. XIV. Colony color and opacity colony variants of Neisseria gonorrhoeae. Infect Immun 19:320-331.
19. Stern A, Brown M, Nickel P, Meyer TF. 1986. Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation. Cell 47:61-71. http://dx.doi.org/10.1016/0092-8674(86)90366-1.
20. Weiser JN, Austrian R, Sreenivavas PK, Masure HR. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 62:2582-2589.
21. McCarter LL. 1998. OpaR, a homolog of Vibrio harveyi LuxR controls opacity in Vibrio parahaemolyticus. J Bacteriol 180:3166-3173.
22. Manso AS, Chai MH, Atack JM, Furi L, De Ste Croix M, Haigh R, Trappetti C, Ogunniyi AD, Shewell LK, Boitano M, Clark TA, Korlach J, Blades M, Mirkes E, Gorban AN, Paton JC, Jennings MP, Oggioni MR. 2014. A random six-phase switch regulates pneumococcal virulence via global epigenetic changes. Nat Commun 5:5055. http://dx.doi.org/10.1038/ncomms6055.
23. van der Woude M, Braaten B, Low D. 1996. Epigenetic phase variation of the pap operon in Escherichia coli. Trends Microbiol 4:5-9. http://dx.doi .org/10.1016/0966-842X(96)81498-3.
24. Henderson IR, Meehan M, Owen P. 1997. A novel regulatory mechanism for a novel phase-variable outer membrane protein of Escherichia coli. Adv Exp Med Biol 412:349-355.
25. Davidsen T, Tonjum T. 2006. Meningococcal genome dynamics. Nat Rev Microbiol 4:11-22. http://dx.doi.org/10.1038/nrmicro1324.
26. Jacobs AC, Thompson MG, Black CC, Kessler JL, Clark LP, McQueary CN, Gancz HY, Corey BW, Moon JK, Si Y, Owen MT, Hallock JD, Kwak YI, Summers A, Li CZ, Rasko DA, Penwell WF, Honnold CL, Wise MC, Waterman PE, Lesho EP, Stewart RL, Actis LA, Palys TJ, Craft DW, Zurawski DV. 2014. AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. mBio 5(3):e01076-14. http://dx.doi.org /10.1128/mBio.01076-14.
27. Adams MA, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ, MacDonald IJ, Martin KM, Russo T, Campagnari AA, Hujer AM, Bonomo RA. 2008. Comparative genome sequence analysis of multidrugresistant Acinetobacter baumannii. J Bacteriol 190:8053-8064. http://dx .doi.org/10.1128/JB.00834-08.
28. Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, Gerstein M, Snyder M. 2007. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 21:601-614. http://dx.doi.org/10.1101/gad.1510307.
29. Miller MB, Bassler BL. 2001. Quorum sensing in bacteria. Annu Rev Microbiol 55:165-199. http://dx.doi.org/10.1146/annurev.micro.55.1.165.
30. Fuqua C, Winans SC, Greenberg EP. 1996. Census and consensus in bacterial ecosystems: the LuxR-LuxI family of quorum sensing transcriptional regulators. Annu Rev Microbiol 50:727-751.
31. Niu C, Clemmer KM, Bonomo RA, Rather PN. 2008. Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J Bacteriol 190:3386-3392. http://dx.doi.org/10.1128/JB.01929-07.
32. Stacy DM, Welch MA, Rather PN, Blackwell HE. 2012. Attenuation of quorum sensing in the pathogen Acinetobacter baumannii using nonnative N-acyl homoserine lactones. ACS Chem Biol 19:1719-1728. http://dx.doi.org/10.1021/cb300351x.
33. McQueary CN, Kirkup BC, Si Y, Barlow M, Actis LA, Craft DW, Zurawski DV. 2012. Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface associated motility. J Microbiol 50:434-443. http://dx.doi.org/10.1007/s12275-012-1555-1.
34. Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC, Jr, Mylonakis E. 2009. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 53:2605-2609. http://dx.doi.org/10.1128/AAC.01533-08.
35. Gaddy JA, Arivett BA, McConnell MJ, Lopez-Rojas R, Actis LA. 2012. Role of acetobactin mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect Immun 80:1015-1024. http://dx.doi.org/10.1128/IAI.06279-11.
36. Ramarao N, Nielsen-Leroux C, Lereclus D. 2012. The insect Galleria mellonella as a powerful infection model to investigate bacterial pathogenesis. J Vis Exp 11(70):e4392. http://dx.doi.org/10.3791/4392.
37. Dubnau D, Losick R. 2006. Bistability in bacteria. Mol Microbiol 61:564-572. http://dx.doi.org/10.1111/j.1365-2958.2006.05249.x.
38. Gallagher LA, Ramage E, Weiss EJ, Radey M, Hayden HS, Held KG, Huse HK, Zurawski DV, Brittnacher MJ, Manoil C. 6 April 2015. Resources for genetic and genomic analysis of the emerging pathogen Acinetobacter baumannii. J Bacteriol http://dx.doi.org/10.1128/JB.00131-15.